Nexien BioPharma Inc (NXEN)

[Renegades17]

Option value of the cannabis drug

If the company gets expedited approval of the cannabis drug, the market cap potential could expand dramatically. Right now, it seems like a $3-$5 target is very much possible, but it's a fluid target with very little downside IMO.

I have over 5% of the float locked down. We still haven't seen the algos go nuts yet with volume. In those situations, the float usually turns over multiple times. I suspect it will take a PR or filing with more details on the merger for that to happen, but you never know. A day trading email list could spark a frenzy too.

Intiva has every incentive to push the stock up to raise equity to fund development of the drug. They'll likely want to uplift to Nasdaq too to appeal to institutional investors.